Date: March 11, 2020|Source: Bayer

Study to gather information about proper dosing and safety of the Oral FXIa Inhibitor BAY 2433334 in patients following a recent non cardioembolic Ischemic stroke which occurs when a blood clot has formed somewhere in the human body (but not in the heart) – Principle Investigator